BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wahab MA, El Hanafy E, El Nakeeb A, Ali MA. Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period). World J Gastrointest Surg 2017; 9(2): 61-67 [PMID: 28289511 DOI: 10.4240/wjgs.v9.i2.61]
URL: https://www.wjgnet.com/1948-9366/full/v9/i2/61.htm
Number Citing Articles
1
D. Kyziridis, A. Kalakonas, K. Zarambouka, C. Hristakis, Antonios-Apostolos K. Tentes. Cytoreductive Surgery and HIPEC for Recurrent Fibrolamellar Hepatocellular Carcinoma with Peritoneal CarcinomatosisJournal of Gastrointestinal Cancer 2020; 51(1): 300 doi: 10.1007/s12029-019-00236-7
2
Anisha Jain, Benjamin Mazer, Yanhong Deng, Maria Ciarleglio, Dhanpat Jain, Tamar Taddei, Xuchen Zhang. Hepatocellular CarcinomaAmerican Journal of Clinical Pathology 2022; 157(2): 305 doi: 10.1093/ajcp/aqab125
3
Sara Bedrose, Marilyne Daher, Lina Altameemi, Mouhammed Amir Habra. Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future DirectionsCancers 2020; 12(2): 508 doi: 10.3390/cancers12020508
4
Dajana Glavas, Quoc Riccardo Bao, Marco Scarpa, Cesare Ruffolo, Zachary J. Brown, Timothy M. Pawlik, Gaya Spolverato. Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysisJournal of Gastrointestinal Surgery 2023; 27(4): 705 doi: 10.1007/s11605-023-05621-z
5
Jyotsna Gummadi, Xin Wang, Changqing Xie. Current Advances in the Treatment of Fibrolamellar Carcinoma of LiverJournal of Hepatocellular Carcinoma 2023; : 745 doi: 10.2147/JHC.S406902
6
Cassandra A. Kersten, Elise N. Sloey, Eric Zhou, Ying Peng, Michael S. Torbenson, Yi Guo. Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosisLiver Research 2017; 1(4): 187 doi: 10.1016/j.livres.2017.12.003
7
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster, Peter Galle. Systemic treatment of HCC in special populationsJournal of Hepatology 2021; 74(4): 931 doi: 10.1016/j.jhep.2020.11.026
8
Diagnostic Pathology: Pediatric Neoplasms2018; : 624 doi: 10.1016/B978-0-323-54806-9.50151-8
9
Susan Shyu, Syed Z. Ali. Significance of hepatocyte atypia in liver fine needle aspirationDiagnostic Cytopathology 2022; 50(4): 186 doi: 10.1002/dc.24851
10
Allison F. O'Neill, Alanna J. Church, Antonio R. Perez-Atayde, Raja Shaikh, Karen J. Marcus, Khashayar Vakili. Fibrolamellar carcinoma: An entity all its ownCurrent Problems in Cancer 2021; 45(4): 100770 doi: 10.1016/j.currproblcancer.2021.100770
11
Hiroki Tanaka, Susumu Hijioka, Hiromichi Iwaya, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Ayako Ito, Naosuke Kuraoka, Shinpei Matsumoto, Masahiro Obata, Yusuke Kurita, Muneji Yasuda, Yasuhiro Shimizu, Hiroaki Kuroda, Yozo Sato, Masataka Haneda, Eiichi Sasaki, Yasushi Yatabe, Kazuo Hara. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary TherapyInternal Medicine 2018; 57(24): 3537 doi: 10.2169/internalmedicine.1243-18
12
Akira Watanabe, Norifumi Harimoto, Hideyuki Saito, Reika Kawabata-Iwakawa, Takaomi Seki, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Kenichiro Araki, Hayato Ikota, Takashi Ishige, Koshi Mimori, Ken Shirabe. Fibrolamellar hepatocellular carcinoma: a case report and gene analysisSurgical Case Reports 2023; 9(1) doi: 10.1186/s40792-023-01751-3
13
Walaa Abdelhamed, Mohamed El-Kassas. Fibrolamellar hepatocellular carcinoma: A rare but unpleasant eventWorld Journal of Gastrointestinal Oncology 2022; 14(6): 1103-1114 doi: 10.4251/wjgo.v14.i6.1103
14
Sebastian Mafeld, Jeremy French, Dina Tiniakos, Beate Haugk, Derek Manas, Peter Littler. Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical ResectionCardioVascular and Interventional Radiology 2018; 41(5): 816 doi: 10.1007/s00270-018-1903-6
15
Cassandra A. Kersten, Elise N. Sloey, Eric Zhou, Ying Peng, Michael S. Torbenson, Yi Guo. WITHDRAWN: Fibrolamellar hepatocellular carcinoma: Exploring molecular mechanisms and differentiation pathways to better understand disease outcomes and prognosisLiver Research 2018;  doi: 10.1016/j.livres.2017.12.011
16
Georgios Polychronidis, Anastasia Murtha-Lemekhova, Juri Fuchs, Evdokia Karathanasi, Katrin Hoffmann. A Multidisciplinary Approach to the Management of Fibrolamellar Carcinoma: Current Perspectives and Future ProspectsOncoTargets and Therapy 2022; : 1095 doi: 10.2147/OTT.S296127
17
Andrew Melehy, Vatche Agopian. Treating rare tumors with liver transplantationCurrent Opinion in Organ Transplantation 2024; 29(1): 30 doi: 10.1097/MOT.0000000000001118
18
Tiantian Fu, Hong Ding, Chen Xu, Yuli Zhu, Liyun Xue, Feng Lin. Imaging findings of fibrolamellar hepatocellular carcinomas on ultrasonography: A comparison with conventional hepatocellular carcinomas1Clinical Hemorheology and Microcirculation 2021; 77(1): 49 doi: 10.3233/CH-200896
19
Daryl Ramai, Andrew Ofosu, Jonathan K. Lai, Zu-Hua Gao, Douglas G. Adler. Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational StudyDigestive Diseases and Sciences 2021; 66(1): 308 doi: 10.1007/s10620-020-06135-3
20
Ryota Matsuki, Naohiro Okano, Nobuhiro Hasui, Shohei Kawaguchi, Hirokazu Momose, Keiichiro Kitahama, Kiyotaka Nagahama, Masaharu Kogure, Yutaka Suzuki, Fumio Nagashima, Junji Shibahara, Hideaki Mori, Yoshihiro Sakamoto. Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting PseudoprogressionLiver Cancer 2023; 12(2): 180 doi: 10.1159/000527250
21
Shaotian Qiu, Rui Chen, Jiaxuan Hu, Tao Han. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matchingScandinavian Journal of Gastroenterology 2023; 58(11): 1351 doi: 10.1080/00365521.2023.2227305